Lesion detectability of a gamma camera based coincidence system with FDG in patients with malignant tumors: A comparison with dedicated positron emission tomography

Annals of Nuclear Medicine

Volumn 18, Issue 2, 2004, Pages 131-136

  Koga, Hirofumi ^a   Sasaki, Masayuki ^b   Kuwabara, Yasuo ^a   Nakagawa, Makoto ^a   Hayashi, Kazutaka ^a   Kaneko, Koichiro ^a   Chen, Tao ^a   Honda, Hiroshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Coincidence PET; Dedicated PET; FDG

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE TUMOR; BREAST CANCER; CANCER CLASSIFICATION; COLON CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ESOPHAGUS CANCER; FEMALE; GAMMA CAMERA BASED COINCIDENCE DETECTOR SYSTEM; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION ATTENUATION; RISK FACTOR; SCHOOL CHILD; SCINTILLATION CAMERA; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TUMOR DIAGNOSIS; TUMOR VOLUME;

EID: 3042840617     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02985103     Document Type: Article

References (22)

1. Delbeke D, Martin WH. Positron emission tomography imaging in oncology. Radiol Clin North Am 2001; 39: 883-917.
2. 18F-FDG detection with a dual-head coincidence camera: a review. Eur J Nucl Med 2001; 28: 763-778.
3. Muehllehner G, Geagan M, Countryman P, Nellemann P. SPECT scanner with PET coincidence capability [abstract]. J Nucl Med 1995; 36: 70P.
4. Bailey D, Zito F, Gilardi M, Savi A, Fazio F, Jones T. Performance comparison of a state-of-the-art neuro-PET scanner and a dedicated neuro-PET scanner. Eur J Nucl Med 1994; 21: 381-387.
5. Stokkel M, Terhaard C, Mertens I, Hordijk G, va Rijk P. Fluorine-18-FDG detection of laryngeal cancer postradiotherapy using dual-head coincidence imaging. J Nucl Med 1998; 39: 1385-1387.
6. 18F-FDG in the staging of non-Hodgkin's lymphoma. J Nucl Med 2001; 42: 601-608.
7. 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras. J Nucl Med 1999; 40: 574-578.
8. Tatsumi M, Yutani K, Watanabe Y, Miyoshi S, Tomiyama N, Johkoh T, et al. Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: comparison with FDG PET. J Nucl Med 1999; 40: 566-573.
9. Shreve PD, Steventon RS, Deters EC, Kison PV, Gross MD, Wahl RL. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner. Radiology 1998; 207: 431-437.
10. Coleman R. Camera-based PET: the best is yet to come. J Nucl Med 1997; 38: 1796-1797.
11. Steinert H, Voellmy D, Trachsel C, Bicik I, Buck A, Huch R, et al. Planar coincidence scintigraphy and PET in staging malignant melanoma. J Nucl Med 1998; 39: 1892-1897.
12. Delbeke D, Sandler MP. The role of hybrid cameras in oncology. Semin Nucl Med 2000; 30: 268-280.
13. Boren EJ, Delbeke D, Ptton J, Sandler M. Comparison of FDG PET and positron coincidence detection imaging using a dual-head gamma camera with 5/8-inch NaI(Tl) crystals in patients with suspected body malignancies. Eur J Nucl Med 1999; 26: 379-387.
14. Zimny M, Kaiser H, Cremerius U, Reinartz P, Schreckenberger M, Sabri M, et al. Dual-head gamma camera 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography in oncological patients: effects of non-uniform attenuation correction on lesion detection. Eur J Nucl Med 1999; 26: 818-823.
15. Kotzerke J, Guhlmann A, Moog F, Frickhofen N, Reske SN. Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma. Eur J Nucl Med 1999; 26: 31-38.
16. Bengel FM, Ziegler SI, Avril N, Weber W, Laubenbacher C, Schwaiger M. Whole-body positron emission tomography in clinical oncology: comparison between attenuation-corrected and uncorrected images. Eur J Nucl Med 1997; 24: 1091-1098.
17. Farguhar TH, Llacer J, Hoh CK, Czernin J, Gambhir SS, Seltzer MA, et al. ROC and localization ROC analyses of lesion detection in whole-body FDG PET: effects of acquisition mode, attenuation correction and reconstruction algorithm. J Nucl Med 1999; 40: 2043-2052.
18. Coleman R, Laymon C, Turkington T. FDG imaging of lung nodules: a phantom study comparing SPECT, camera-based PET and dedicated PET. Radiology 1999; 26: 823-828.
19. Weber WA, Neverve J, Sklarek J, Ziegler SI, Bartenstein P, King B, et al. Imaging of lung cancer with fluorine-18 fluorodeoxyglucose: comparison of a dual-head gamma camera in coincidence mode with a full-ring positron emission tomography system. Eur J Nucl Med 1999; 26: 388-395.
20. 18F-FDG PET images obtained 2 hours after intravenous injection in liver tumor. Ann Nucl Med 2002; 16: 169-176.
21. Kubota K, Itoh M, Ozaki K, Ono S, Tashiro M, Yamaguchi K, et al. Advantage of delayed whole-body FDG-PET imaging for tumour detection. Eur J Nucl Med 2001; 28: 696-703.
22. Paul AK, Tatsumi M, Yutani K, Fujino K, Hashikawa K, Nishimura T. Effects of iterative reconstruction on image contrast and lesion detection in gamma camera coincidence imaging in lung and breast cancers. Nucl Med Commun 2002; 23: 103-110.